SPN-810
810P201
Phase 2 small_molecule completed
Quick answer
SPN-810 for Attention Deficit Disorder With Hyperactivity is a Phase 2 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Attention Deficit Disorder With Hyperactivity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed